Related Experiment Videos
Microscopic polyangiitis and polyarteritis nodosa: how and when do they start?
Christian Agard1, Luc Mouthon, Alfred Mahr
1Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, France.
Objective:
To describe initial clinical symptoms attributable to microscopic polyangiitis (MPA) or polyarteritis nodosa (PAN).
Methods:
We retrospectively reviewed the medical files of 72 patients (mean followup 6.7 years) with biopsy-proven MPA (n = 36) or PAN (n = 36).
Results:
Initial manifestations were similar in both entities except for peripheral neuropathy (P = 0.02) and gastrointestinal tract involvement (P = 0.006), which were significantly more frequent in PAN, and general signs alone in MPA (8%; P = 0.02). The mean time to diagnosis was 9.8 +/- 19.4 months; 35% of the patients died and 26% relapsed; significantly more MPA than PAN patients relapsed (P = 0.03). Time to diagnosis >/=90 days was associated with a trend toward more patients relapsing (P = 0.12), but not with an increased risk of mortality.
Conclusion:
Initial symptoms of MPA and PAN are usually nonspecific and last for several months before the diagnosis is made. A longer time to diagnosis is associated with a tendency to a higher relapse rate.
Insights
Initial symptoms for microscopic polyangiitis (MPA) and polyarteritis nodosa (PAN) are often nonspecific, delaying diagnosis for months. Longer diagnostic times correlate with increased relapse rates in these vasculitis patients.
Area of Science:
- Rheumatology
- Vasculitis Research
- Internal Medicine
Background:
- Microscopic polyangiitis (MPA) and polyarteritis nodosa (PAN) are rare systemic vasculitides.
- Distinguishing between MPA and PAN based on initial symptoms can be challenging.
- Early diagnosis is crucial for effective management and improved patient outcomes.
Purpose of the Study:
- To delineate the initial clinical presentations of microscopic polyangiitis (MPA) and polyarteritis nodosa (PAN).
- To identify key differences in early symptoms that may aid in differentiating between MPA and PAN.
- To analyze the impact of time to diagnosis on patient outcomes, including mortality and relapse rates.
Main Methods:
- Retrospective review of medical records for 72 patients with biopsy-proven MPA (n=36) or PAN (n=36).
- Analysis of initial clinical manifestations, diagnostic timelines, and patient outcomes (mortality, relapse).
- Statistical comparison of symptom frequency and outcome measures between MPA and PAN cohorts.
Main Results:
- Initial symptoms were largely similar between MPA and PAN.
- Peripheral neuropathy and gastrointestinal involvement were significantly more common in PAN.
- Microscopic polyangiitis (MPA) showed a higher rate of relapse compared to polyarteritis nodosa (PAN) (P = 0.03).
- A diagnosis time exceeding 90 days showed a trend towards higher relapse rates (P = 0.12).
Conclusions:
- Initial symptoms of MPA and PAN are typically nonspecific, often leading to diagnostic delays.
- Delayed diagnosis (>/=90 days) is associated with an increased tendency for relapse.
- Prompt recognition and diagnosis are vital for managing MPA and PAN to mitigate long-term complications.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Diabetic Nephropathy
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetic Retinopathy
Chronic Inflammation: Introduction
Mechanism of Angiogenesis